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Extra-virgin olive oils (EVOO), high in phenolic compounds with antioxidant properties, could be partly responsible for the lower mortality and
incidence of cancer and CVD in the Mediterranean region. The present study aims to measure oxidative DNA damage in healthy human subjects
consuming olive oils with different concentrations of natural phenols. A randomised cross-over trial of high-phenol EVOO (high-EVOO; 592 mg
total phenols/kg) v. low-phenol EVOO (low-EVOO; 147 mg/kg) was conducted in ten postmenopausal women in Florence. Subjects were asked to
substitute all types of fat and oils habitually consumed with the study oil (50 g/d) for 8 weeks in each period. Oxidative DNA damage was
measured by the comet assay in peripheral blood lymphocytes, collected at each visit during the study period. Urine samples over 24 h were col-
lected to measure the excretion of the olive oil phenols. The average of the four measurements of oxidative DNA damage during treatment with
high-EVOO was 30 % lower than the average during the low-EVOO treatment (P¼0·02). Urinary excretion of hydroxytyrosol and its metabolite
homovanillyl alcohol were significantly increased in subjects consuming high-EVOO. Despite the small sample size, the present study showed
a reduction of DNA damage by consumption of an EVOO rich in phenols, particularly hydroxytyrosol.
Extra-virgin olive oil: Phenols: Hydroxytyrosol: Oxidative DNA damage: Cancer
In recent years, evidence has accumulated of a lower mortality
and incidence of cancer and CVD in the Mediterranean area,
with regard to the rest of Europe and other parts of the indus-
trialised world (Owen et al. 2004). Various aspects of diet
have been hypothesised as possible determinants of this
effect, but the most characterising dietary habit in this area
is the daily consumption of olive oil as the main fat used
for seasoning and for food preparation. Other hypothesised
health-enhancing ingredients, such as vegetables, fruit,
whole grains, nuts, fish, and possibly red wine, are commonly
consumed also in other parts of the Western world, and their
benefit for reducing chronic diseases can be observed even
within non-Mediterranean countries.
We know much less about the effects of different qualities
of olive oils. This quality is defined by European regulations
(European Commission, 2003), which state the requirements
for each commercial type of olive oil: extra-virgin, virgin,
olive oil, and finally olive-pomace oil. Even extra-virgin
olive oils (EVOO) can differ in terms of their MUFA content,
tocopherols, and a large variety of minor polar components,
mainly phenols. The phenolic fraction includes hydroxytyrosol
and its precursors that have potent antioxidant capacity due to
their catecholic moiety (Montedoro et al. 1992a,b). It is note-
worthy that olive oil phenols are absorbed and excreted by
animals (Visioli et al. 2001) and man (Visioli et al. 2000b;
Vissers et al. 2001). Researchers have focused their attention
on the hypothesised reduction of oxidation of LDL by olive oil
phenols, which could potentially reduce atherosclerosis; some
results have been encouraging but others have not (Vissers
et al. 2001; Gimeno et al. 2002; Moschandreas et al. 2002).
A possible role of hydroxytyrosol in protecting DNA from
oxidative damage has been shown in vitro (Deiana et al.
1999) and only recently also in vivo (Weinbrenner et al.
2004). We therefore planned a pilot study to assess in vivo,
*Corresponding author: Dr Simonetta Salvini, fax þ39 055 32697829, email s.salvini@cspo.it
Abbreviations: EPIC, European Prospective Investigation into Cancer and Nutrition; EVOO, extra-virgin olive oil; high-EVOO, high-phenol extra-virgin olive oil;
HVAlc, homovanillyl alcohol; low-EVOO, low-phenol extra-virgin olive oil.
British Journal of Nutrition (2006), 95, 742–751 DOI: 10.1079/BJN20051674
q The Authors 2006
in subjects consuming their habitual diets, the antioxidant
effects of an EVOO rich in naturally occurring phenols and
compare it with a similar quality EVOO with a concentration
of phenols in the lower range of what is commonly available
on the Italian market.
Materials and methods
Study design
A randomised cross-over intervention trial of high-phenol
EVOO (high-EVOO) v. low-phenol EVOO (low-EVOO)
was planned, to evaluate their effects on oxidative DNA
damage in healthy volunteers.
The present pilot study consisted of two intervention
periods of 8 weeks each, the first in September–November
2002, and the second after an 8-week wash-out period, in Jan-
uary–March 2003. Participants were randomised to the
sequence of consumption of the two study oils (high-EVOO
in the first period and low-EVOO in the second period, or
vice versa), and were asked to substitute all fats and oils
usually consumed for seasoning and food preparation with
the specifically selected study oils, and to consume at least
50 g daily of the assigned study oils in raw form in addition
to the study oils necessary for cooking. Subjects were also
asked to use the study oils when preparing the meals for
other members of the family and when eating away from
home. Therefore, study oils were provided at each visit in a
quantity estimated to be sufficient for the whole family for a
period of 2 weeks. Study participants and personnel were una-
ware of the treatment assignment. However, because of the
very marked difference between the taste of a phenol-rich
and a phenol-poor oil, at follow-up visits the study personnel
had quite clear clues from volunteers concerning their study
oil consumption. These perceptions were not disclosed to
study subjects.
Apart from the fat substitution, subjects were instructed to
stay on their habitual diet. Volunteers were seen at our clinic
on ten occasions (at the baseline and thereafter every 2
weeks) for body measurements (height at the first visit, and
weight, waist and hip circumferences), blood pressure and
heart rate, blood drawing, 24 h urine collection and 24 h
diet recall interview at the baseline and at each subsequent
visit. In addition to these procedures, at the baseline visit
subjects were asked to report their dietary and lifestyle
habits by filling in the European Prospective Investigation
into Cancer and Nutrition (EPIC) study self-administered
food-frequency questionnaire and lifestyle questionnaire
(Pala et al. 2003). At the last visit in each of the two periods
(fifth and tenth visit), subjects were asked questions about the
acceptance of the assigned treatment and about their partici-
pation in the trial.
During the whole study period, subjects were seen at the
study clinic ten times; five times in the first study period
and five times in the second. During the 8-week washout,
they were asked to consume their habitual fats and oils.
Subjects
Flyers about the study were distributed and posted in our
clinics and among women’s health initiative groups. Selection
criteria included being a healthy postmenopausal woman (no
menstrual periods in the previous 12 months), non-smoker,
with no history of treated hypercholesterolaemia and/or hyper-
tension, no chronic use of aspirin or antioxidant vitamins, and
without history of cancer, CVD, diabetes or other important
chronic conditions. Criteria for eligibility also included resid-
ing in the Florence area, consuming most of the meals at home
(no more than two meals per week outside home) and consum-
ing less than two glasses red wine per d to avoid interference
between the effects of red wine phenols and the olive oil phe-
nols. Interested subjects were asked to contact us by tele-
phone, and were asked specific questions checking for
eligibility criteria. Out of thirty-five women who contacted
us, thirteen were found eligible and twelve agreed to enter
the trial. Selected women were invited to a meeting in
which the study was described in detail, and printed material
and informed consent forms were provided to the subjects.
Individual appointments for the baseline visit were set up
and volunteers were instructed to collect their urine during
the 24 h before the visit. Three 1 litre, disposable containers
were given for urine collection, together with a 1 ml vial of
40mM-butylated hydroxytoluene to be poured into each con-
tainer just before starting the urine collection. Subjects were
requested to dispose of the first urine in the morning of the
collection day and to collect subsequently each voided urine
in the following 24 h, including the first urine on the following
day. At each visit, subjects were given containers for the fol-
lowing urine collection.
Before starting the second phase of the trial (after 8 weeks
washout), two women, both initially assigned to the low-
phenol olive oil, discontinued their participation. Ten volun-
teers were therefore left for the analyses. The flow of study
subjects is presented in Fig 1.
Dietary intake measurements
At baseline, dietary habits were measured by the EPIC food-
frequency questionnaire. Frequencies of consumption of stan-
dard or specifically reported portions were transformed into
weight (g) of daily consumed food and daily nutrient intakes
(Pisani et al. 1997; Pala et al. 2003). In addition, at each of
the ten visits, subjects were interviewed by the study dietitian
about food and beverages consumed in the previous 24 h. Food
consumption data were transformed into average daily con-
sumption of food, beverages and nutrients, by means of the
nutritional software Microdiet (University of Salford, UK).
The software includes, in addition to UK food composition
data, also the same Italian food tables applied to the EPIC
food-frequency questionnaire (Salvini et al. 1998). The com-
position of the study oils was also entered into the software
to allow estimation of daily intake of olive oil phenols
during the two intervention periods.
Selection of study oils
Aiming to select a very high-phenol olive oil and one in the
lower bound of possible concentrations, several batches of
high-quality EVOO, originating from different parts of the
Mediterranean basin, were selected and analysed. All selected
oils were in line with commercial requirements for EVOO,
showing very low acidity (range 0·1–0·8 %) and low total
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peroxides (1·8–12·3 meq O2/kg). The concentration of MUFA
ranged from 73·9 to 79·4 %, and a-tocopherol varied from 135
to 290 mg/kg. Total phenols ranged from 87 to 806 mg/kg and
also the fraction of free hydroxytyrosol showed a very large
variation (0·4–19 mg/kg). After organoleptic examination by
study personnel to test the palatability of the samples, the
final selection was made. A blend of Italian EVOO, predomi-
nantly from the southern Italian region of Puglia (mostly Cor-
atina cultivar), was chosen as the high-phenol oil (total
phenols 592 mg/kg), and a sample of a blend of EVOO
mainly from the Liguria region was chosen as the low-
phenol olive oil (total phenols 147 mg/kg). The main chemical
characteristics of the selected olive oils are shown in Table 1.
To measure the total phenols in the study oils, extraction
and HPLC–diode array detection–MS analysis were applied
according to previous studies (Romani et al. 2001; Pinelli
et al. 2003; Mulinacci et al. 2006b). The free and linked
form of hydroxytyrosol were evaluated after the acidic
hydrolysis of the phenolic olive oil fraction (Mulinacci et al.
2006a).
For the analysis of the fatty acids, a Fisons 8060 gas chro-
matograph equipped with a split-splitless injector and a flame
ionisation detector was used. The fused silica column was an
SP 2380, 30 m £ 0·32 mm internal diameter, 0·20mm film
thickness (Supelco, Bellefonte, PA, USA). The column tem-
perature was set at 1658C for 5 min, then programmed to
2208C at 58C/min followed by 10 min isotherm. The injector
and detector temperature was 2208C. The carrier gas (He)
flow-rate was 0·6 ml/min. The fatty acids were analysed as
methyl ester derivatives prepared by trans-esterification with
a cold methanolic solution of potassium hydroxide (IUPAC
standard method 2·301; IUPAC, 1987).
The tocopherols composition was determined by normal-
phase HPLC with spectrofluorometric detection (Dieffenba-
cher & Pocklington, 1992). A Knauer K-501 pump equipped
with a Jasco FP-1520 fluorescence detector (lex 290 nm, lem
330 nm) and a silica column Spherisorb S5W,
250 mm £ 4·6 mm internal diameter, 5mm particle size was
used. The elution was carried out in isocratic condition with
n-hexane containing 1 % (v/v) isopropyl alcohol as the
mobile phase. A sample of 250 mg oil was dissolved in
25 ml mobile phase in a volumetric flask before analysis.
Biological markers
Peripheral blood (30 ml) was collected from an antecubital
vein at each visit. Blood was drawn in different vacutainers
depending on the analyses to be performed. Samples for
comet assay were sent within 3 h from collection to the appro-
priate laboratory. Additional samples drawn in EDTA and in
lithium heparin were centrifuged at 3200 g for 20 min:
plasma, buffy coat, and erythrocytes were separated into
1 ml vials and stored at 2808C in alarmed freezers until ship-
ment to the appropriate laboratory or stored for future ana-
lyses. All analyses were carried out blinded to study
identifiers by laboratory personnel.
Comet assay. One EDTA tube was brought within 3 h
from collection to the laboratory for analyses of DNA
damage. Lymphocytes were isolated utilising Lymphoprep
separation medium (Gibco, UK). Blood samples of 3 ml
were diluted 1:2 with PBS and layered on an equal volume
of Lymphoprep medium in a centrifuge tube. After centrifu-
gation at 1000 g for 20 min, gradient-separated lymphocytes
were recovered, diluted 1:4 with PBS and centrifuged again
at 1000 g for 10 min. The resulting cell pellets were re-sus-
pended in PBS and counted in a Neubauer chamber.
Table 1. Composition of the selected study oils in terms of
phenols and tocopherols (mg/kg) and fatty acids (%)
Study oils
Low-EVOO High-EVOO
Hydroxytyrosol (free form) 1·6 12·2
Tyrosol 2·6 14·6
Elenolic acid derivatives 2·4 6·7
Elenolic acid 13·5 47·9
3,4-DHPEA-EDA* 4·7 51·3
Total secoiridoids derivatives 114·8 351·4
Oleuropein aglycone 6·3 107·6
Luteolin 1·2 0·2
Total phenols 147·3 591·8
Total hydroxytyrosol† 15·4 157·3
a-Tocopherol 220·0 275·0
b-Tocopherol 1·1 2·0
g-Tocopherol 1·4 11·9
Saturated fatty acids (%) 15·8 12·6
MUFA (%) 73·8 78·5
PUFA (%) 10·3 8·9
High-EVOO, high-phenol extra-virgin olive oil; low-EVOO, low-phenol
extra-virgin olive oil.
* 3,4 Dialdehydic form of elenolic acid linked to hydroxytyrosol.
† Free and linked forms, evaluated after acidic hydrolysis.
For details of procedures, see p. 743.
Fig. 1. Trial profile, summarising the flow of the study subjects. High-EVOO,
high-phenol extra-virgin olive oil; low-EVOO, low-phenol extra-virgin olive oil.
For details of subjects and procedures, see p. 743.
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Membrane integrity was assessed by the trypan blue exclusion
method. The comet assay was used to measure both DNA
breaks and oxidised bases. Samples of the lymphocyte suspen-
sion containing about 200 000 cells were further centrifuged at
250 g for 10 min, and the resulting pellets were re-suspended
in low-melting point agarose, layered on microscopic slides
and run through the comet assay as previously described (Gio-
vannelli et al. 2003). Detection of oxidative DNA damage was
carried out by means of the enzyme formamidopyrimidine
DNA glycosylase, which introduces breaks at sites of oxidised
purines such as 8-oxo-20-deoxyguanosine.
The value of DNA damage (expressed as % DNA in the
comet tail) obtained in slides without enzyme incubation esti-
mated the basal number of DNA strand breaks, whereas
specific DNA oxidative damage on purines was assessed for
each subject by subtracting the percentage DNA in the
comet tail found in the buffer-incubated slides from that
obtained in the slides incubated with formamidopyrimidine
DNA glycosylase.
Microscopic analysis was carried out by means of a Labo-
phot-2 microscope (Nikon, Tokyo, Japan) provided with epi-
fluorescence and equipped with a rhodamine filter
(excitation wavelength 546 nm; barrier 580 nm). The images
of fifty randomly chosen nuclei per slide were captured and
analysed using a custom-made imaging software coupled
with a CCD camera (model C5985; Hamamatsu, Sunayama-
Cho, Japan). Each point was run in duplicate. Data were
expressed as percentage DNA migrated in the tail, a parameter
that is directly correlated with the number of breaks. Cali-
bration of the method with g-rays, which induce a known
dose-dependent frequency of breaks, showed that 10 % DNA
in the tail corresponds to about 1·3 breaks per 109 Da DNA.
In vitro exposure to hydrogen peroxide. In order to evalu-
ate the response of lymphocytes to oxidative stress, samples of
the isolated cells were exposed to H2O2 in vitro. Immediately
after isolation, 400 000 cells from each subject were re-sus-
pended in 1 ml PBS containing 25mM-H2O2. This concen-
tration of H2O2 was chosen on the basis of preliminary
experiments in which the effect of different doses had been
evaluated. The rationale for this choice was that the 25mM
concentration induced an increase in DNA damage, which
was significant (þ150 % above basal levels) and at the same
time not overly strong, so that even weak protective effects
of olive oil phenols could be detected. The incubation with
H2O2 was conducted for 5 min at 48C to inhibit DNA repair.
After completing the incubation, the lymphocytes were centri-
fuged at 250 g for 10 min, and the resulting pellets were re-
suspended in low-melting point agarose (two slides for each
experimental point) to be run through the comet assay as
described earlier. Only DNA strand breaks were measured in
this set of experiments.
Plasma antioxidant capacity. The antioxidant capacity of
plasma was evaluated according to a method based on the
inhibition of the radical cation 2-20-azino-di[3-ethylbenzthia-
zoline sulfonate] (ABTSw) formation (Randox Laboratories
Ltd, Crumlin, Co. Antrim, UK) (Miller et al. 1993).
Olive oil phenolics in human urine. At each visit, the 24 h
urine samples collected by the volunteers and stabilised with
butylated hydroxytoluene were weighed, then mixed together
if collected in more than one container, and finally sampled
in fifteen 10 ml vials and frozen at 2208C. Two vials for
each subject were shipped in dry ice to the appropriate labora-
tory. For the quantification of total simple phenols in urine,
360 units b-glucuronidase (Sigma, St Louis, MO, USA)
were added to 1 ml urine after thawing and incubated over-
night at 378C and pH 5. At the end of incubation, each
sample was added with 2H-labelled hydroxytyrosol (0·5mg/
ml) and a-naphthole (1mg/ml), as internal standards for
hydroxytyrosol and for its metabolite homovanillyl alcohol
(HVAlc), respectively. After acidification with 0·3 M-HCl–
acetonitrile (1:1, v/v), urine was extracted twice with three
volumes of ethyl acetate; the organic phase was evaporated
to dryness under N2. The residue was derivatised with a mix-
ture of bis-trimethylsilyl-trifluoro acetamide–pyridine (4:1, v/
v) before the GC–MS analysis. Calibration curves were pre-
pared using 1 ml samples of urine that did not contain the
compounds under investigation. These samples were spiked
with 2H-labelled hydroxytyrosol (0·5mg/ml) and a-naphthole
(1mg/ml) and increasing amounts (10–2000 ng/ml) of auth-
entic hydroxytyrosol and its metabolites; each sample was
then extracted and analysed, as already described. GC–MS
analyses were performed on a CP-Syl8 fused silica capillary
column (Varian Inc., Palo Alto, CA, USA) connected with a
GCQ mass spectrometer (ThermoQuest, Petterson, CA,
USA). Ions at m/z 216 for a-naphthole, at m/z 312 for
HVAlc, 370 and 372 for natural and 2H-labelled hydroxytyro-
sol respectively, were recorded. These ions are selected after
mass spectra obtained from authentic standards (Caruso et al.
2001).
Routine examinations. At the first and last visits of each of
the two treatment periods, a sample was also drawn for routine
laboratory examination. These samples were assayed by stan-
dard procedures at the central laboratory of the Careggi Hos-
pital (Florence, Italy).
Statistical analysis
Descriptive statistics were calculated to provide general infor-
mation on the sample of volunteers.
To evaluate the effect of treatment, of period and to test the
presence of carry-over, responses obtained during the first
period (September–November 2002) were compared with
those obtained in the second period (January–March 2003),
considering the sequence of the treatment, i.e. ‘low–high’ cor-
responding to low-EVOO in the first period and high-EVOO
in the second period and ‘high–low’ corresponding to high-
EVOO in the first period and low-EVOO in the second period.
Indicated by yijk; the mean of the log-transformed values of
the four responses observed on the kth subject in the period
j ¼ 1, 2 of group i ¼ Low, High, we used the usual parame-
terisation, based on Jones & Kenward (1989), yijk ¼ mþ sik þ
pj þ ti þ lij21 þ e ijk; where pj ( j ¼ 1, 2) are the period
effects; ti (i ¼ Low, High) are the direct treatment effects,
lL,1 and lH,1 are the carry-over effect parameters; sik are the
random subject effects with mean 0 and variance ss and e ijk
are white-noise random error.
Exact non-parametric tests for two-period cross-over trials
were applied (Jones & Kenward, 1989). Two-sample exact
Wilcoxon rank-sum tests were applied to assess, for each out-
come, the hypothesis of equality of carry-over effect H0:
l1 ¼ l2, treatment effect H0: tL ¼ tH j l1 ¼ l2 and period
effect H0: p1 ¼ p2 j l1 ¼ l2 and to derive point estimates
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with 95 % CI for the exponential of the differences on treat-
ment (the term exp(tH ¼ tL) gives the geometric mean ratio
by treatment group) and period (the term exp (p1 – p2)
gives the geometric mean ratio by period). All analyses
were carried out with STATA 7 (Stata Statistical Software
release 7; StataCorp LP, College Station, TX, USA).
Ethical considerations
The study was approved by the Florence Health Authority’s
Ethics Committee. All study procedures conformed with the
Declaration of Helsinki for medical research involving
human subjects, as revised in 1983.
Results
The main baseline characteristics of study volunteers are
shown in Table 2. The age range was 47–67 years; the aver-
age BMI was borderline normal (mean 25·1 (range 20·7–27·8)
kg/m2). The average daily energy intake was 9221 (SD 4224)
kJ (2204 (SD 1015) kcal), and was characterised by a 32·9 %
energy intake from fats, with olive oil as the most frequently
consumed added fat (32·8 g/d v. 0·2 g seed oils, 0·6 g margar-
ine and 0·6 g butter and 1·1 g other animal fats). Biochemical
data measured at the baseline showed a mean cholesterol level
of 5·88 (range 4·84–7·33) mmol/l. No statistically significant
differences were observed between sequence of treatment
for any of the considered variables (data not shown).
Table 3 shows the average values of the outcomes of inter-
est, at the baseline and during high-EVOO and low-EVOO
treatment. The intake of total olive oil phenols, as estimated
by the repeated 24 h recalls (four measurements per subject
during high-EVOO and four during low-EVOO), was approxi-
mately four times higher during the treatment with high-
EVOO (mean 34·9 (SD 11·0) mg/d) as compared with the
low-EVOO treatment (mean 9·7 (SD 3·4) mg/d), although the
consumption of the study oil tended to be higher during the
low-EVOO treatment (64·4 (SD 22·5) v. 53·3 (SD 16·1) g/d).
Intake of free hydroxytyrosol was seven-fold during the
high-EVOO. Baseline urinary excretion of hydroxytyrosol
and of its metabolite HVAlc demonstrates that this Tuscan
sample of women is habitually exposed to olive oil phenols:
hydroxytyrosol excretion ranges from 116 to 3146mg/d, and
HVAlc from 25 to 212mg/d. The increased intake of olive
oil phenols affected the excretion of hydroxytyrosol and its
metabolite HVAlc. Fig 2 shows the geometric means of cumu-
lative urinary excretion of hydroxytyrosol and HVAlc, by
treatment sequence and by period. Treatment and period
effects were tested by exact non-parametric tests for two-
period cross-over trials, on log-transformed data, and results
are summarised in Table 4. The ratio of geometric means of
the measurements showed a statistically significant increased
Table 2. Characteristics of the ten postmenopausal women at the baseline visit
(Mean values and standard deviations)
Mean SD 10th Percentile 90th Percentile
Age (years) 57·1 5·9 50·4 66·0
Weight (kg) 60·9 9·2 49·0 71·1
Height (cm) 155·3 8·8 1·42 1·66
BMI (kg/m2) 25·1 2·2 21·8 27·6
Waist:hip ratio 0·8 0·1 0·76 0·90
Systolic blood pressure (mm/Hg) 122·0 14·9 107·5 145·0
Diastolic blood pressure (mm/Hg) 72·0 6·3 62·5 80·0
Pulse rate (frequency/min) 64·6 4·6 57·5 70·0
Average daily dietary intake*
Energy intake
KJ 9221 4244 4487 15 754
Kcal 2204 1015 1073 3543
Protein (% total energy) 15·6 2·3 12·5 18·9
Carbohydrates (% total energy) 46·4 5·4 41·0 57·0
Fats (% total energy) 32·9 4·6 26·3 38·2
Vitamins
Vitamin C (mg) 159·7 72·4 82·9 269·1
Vitamin E (mg) 8·0 3·5 3·5 12·2
b-Carotene (mg) 4634·8 2701·8 1848·5 8853·6
Folates (mg) 307·8 129·2 168·0 485·0
Alcohol (g) 17·0 11·0 2·6 27·4
Added fats (g/d)
Olive oil 32·8 19·4 11·1 61·6
Seed oils 0·2 0·1 0·1 0·4
Margarine 0·6 1·1 0·1 2·1
Butter 0·6 0·8 0·1 2·0
Other animal fat 1·1 1·1 0·0 2·6
Baseline blood levels
Total cholesterol (mmol/l) 5·88 0·77 4·93 6·95
HDL-cholesterol (mmol/l) 1·92 0·38 1·46 2·49
LDL-cholesterol (mmol/l) 3·41 0·66 2·49 4·13
Triacylglycerol (mmol/l) 1·20 0·61 0·73 2·15
Glucose (mmol/l) 4·44 0·56 3·33 5·00
* Data obtained from the food-frequency questionnaire administered at the baseline visit.
For details of subjects and procedures, see p. 743.
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excretion of hydroxytyrosol (treatment effect 2·17; P¼0·01),
HVAlc (treatment effect 3·08; P¼0·019), and total combined
hydroxytyrosol and HVAlc excretion (treatment effect 1·94;
P¼0·01). Phenol excretion was not affected by period, and
no carry-over was detectable for any of the outcomes (data
not shown).
Fig 3 shows the geometric mean ratios of measured DNA
oxidative damage by treatment sequence (high-EVOO v.
low-EVOO) during the intervention period. Measurements
were taken every 2 weeks. Although the effect was not con-
stant over the treatment period, individual differences
showed a reduction of damage mainly in the fourth and fifth
measurement time (i.e. after 6 and 8 weeks of treatment).
Overall, the average of the four measurements during treat-
ment with high-EVOO was always lower than the average
during the low-EVOO treatment (Fig 4). The non-parametric
tests (Table 4) showed a decreased DNA damage, with a
30 % significant reduction of oxidised bases, expressed as
the ratio of the geometric means of the repeated measures
(treatment effect 0·70; 95 % CI 0·56, 0·86; P¼0·019); a non-
significant period effect (lower damage in the winter period)
was also shown. Restricting the analyses on measurements
taken after 6 and 8 weeks, an even stronger result could be
observed (treatment effect 0·53; 95 % CI 0·33, 0·76; data not
shown). DNA breaks were not affected by treatment
(P¼0·352), but were strongly influenced by study period,
with lower breaks in January–March (period effect 0·62;
P¼0·01). Treatment did not affect plasma antioxidant
capacity, but this measure was also affected by period
(period effect 0·64; P¼0·01).
The response of lymphocytes to in vitro induced oxidative
stress was evaluated at the first and fifth measurement time
in both study periods (i.e. at baseline and after 8 weeks of
treatment). No difference in the amount of DNA breakage
induced by H2O2 was found between high-EVOO and low-
EVOO treatment (data not shown).
Table 3. Summary of intakes, excretion, and biomarkers at baseline, and during high-phenol extra-virgin olive oil (high-EVOO)
and low-phenol extra-virgin olive oil (low-EVOO) treatment
(Mean values and standard deviations)
Baseline (n 10) High -EVOO (n 40) Low-EVOO (n 40)
Mean SD Mean SD Mean SD
Intake estimates from 24 h diet recalls
Olive oil (g/d)* 24·5 8·8 53·3 16·1 64·4 22·5
Total olive oil phenols (mg/d) –† – 34·9 11·0 9·7 3·4
Hydroxytyrosol (free form) (mg/d) –† – 0·7 0·3 0·1 0·1
Total hydroxytyrosol (free and linked forms) (mg/d) –† – 8·4k – 1·0k –
24 h urine excretion
Hydroxytyrosol (mg/d) 682·0 924·6 1347·1‡ 1007·2 880·1§ 1451·7
Homovanillyl alcohol (mg/d) 73·8 54·6 444·1‡ 509·0 150·7§ 128·3
Study biomarkers
Oxidised DNA bases (% DNA in comet tail) 11·9 7·67 5·6‡ 5·1 6·5 5·1
Basal DNA breaks (% DNA in comet tail) 12·9 7·0 5·1‡ 1·5 5·0 2·3
Plasma antioxidant capacity (mmol/l) 0·9 0·3 0·9‡ 0·5 0·8 0·5
* Olive oil consumption is slightly underestimated since the study oil included in some home prepared recipes could not be included in this figure,
but contributed to the estimate of phenol intake.
† No estimates of average phenol concentration in commonly consumed olive oils were available.
‡ n 39.
§ n 37.
kEstimated from average olive oil consumption and concentration of free and linked hydroxytyrosol in the study oils.
For details of subjects and procedures, see p. 743.
Fig. 2. Total combined urinary excretion of hydroxytyrosol and homovanillyl alcohol (mmol/l) in ten volunteer subjects by period and treatment sequence. (a) High-
phenol extra-virgin olive oil (high-EVOO) in the first period and low-phenol EVOO (low-EVOO) in the second period; (b) low-EVOO in the first period and high-
EVOO in the second period). Values are geometric means, with 95 % CI represented by vertical bars. For details of subjects and procedures, see p. 743.
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Discussion
Olive oil is the characterising ingredient of diets in the Med-
iterranean basin and the hypothesis that high intakes of olive
oil could reduce cancer incidence is appealing (Willett 1997;
Simopoulos, 2004; Visioli et al. 2004). Despite the limited
number of subjects, the present cross-over trial was able to
show a reduction in DNA oxidative damage in postmenopau-
sal women consuming an EVOO with a high concentration of
total phenols, and of the potent antioxidant hydroxytyrosol. In
the high-EVOO the total content of hydroxytyrosol, both free
and linked, was about ten-fold higher than in the low-EVOO.
The detection of phenols in EVOO is quite recent (Monte-
doro et al. 1992a,b) and various researchers have focused their
attention on their effects (Visioli et al. 1999; Pirisi et al. 2000;
Romani et al. 2001; Conte et al. 2002; Pinelli et al. 2003;
Mulinacci et al. 2005b). Phenols comprise a large family of
molecules and the most abundant in EVOO are tyrosol, hydro-
xytyrosol, and other complex secoiridoids, sharing the
hydroxytyrosol or tyrosol nucleus. They are the major deter-
minants of sensorial characteristics of EVOO and their con-
centration in the oil is related to several factors: cultivar and
environmental characteristics, ripeness of the fruit, and time
and type of milling process. Hydroxytyrosol has powerful
antioxidant potentials (Papadopoulos & Bosku, 1991), protects
LDL from oxidative damage (Visioli et al. 1995; Caruso et al.
1999; Ramirez-Tortosa et al. 1999; Fito et al. 2000) and
decreases F2-isoprostanes excretion (Visioli et al. 2000a).
However, the effect on lipid oxidation was evidenced by
some (Gimeno et al. 2002; Marrugat et al. 2004; Weinbrenner
et al. 2004) but not all intervention trials (Vissers et al. 2001;
Moschandreas et al. 2002).
The focus of our intervention was the effect of hydroxytyr-
osol on DNA oxidation, since a reduction of DNA oxidative
damage is a mechanism underlying possible cancer prevention
by olive oil. Mammalian cells are continuously attacked by
oxygen radicals and such damage, if not appropriately coun-
teracted, contributes to generation of DNA damage and
somatic cell mutation that could direct the cell to a cancerous
transformation (Halliwell, 2000; Marnett, 2000; Neumann
et al. 2003; Saran et al. 2004). Deiana et al. (1999) showed
an inhibition of the peroxynitrate-dependent DNA base modi-
fication in vitro. An in vitro study (Quiles et al. 2002) showed
a lower DNA damage exerted by hydroxytyrosol on human
prostate cells. A recent trial with three olive oils with different
concentration of total phenols showed an effect on the oxi-
dant–antioxidant status of human cells. In particular, 8-oxo-
20-deoxyguanosine in mitochondrial DNA was reduced by
the intake of olive oil phenols in men consuming a very-
low-antioxidant diet (Weinbrenner et al. 2004). Additionally,
Table 4. Summary of treatment and period effects during high-phenol olive oil (high-EVOO) and low-phenol olive oil (low-EVOO)
intervention
(Geometric mean ratios and 95 % confidence intervals)
Treatment effect 95 % CI Period effect 95 % CI
Intake estimates from 24 h diet recalls
Total olive oil phenols intake (mg/24 h) 3·56* 3·01, 4·20 0·99 0·83, 1·14
24 h urine excretion
Hydroxytyrosol excretion (mg/24 h) 2·17* 1·33, 5·54 0·86 0·61, 1·71
Homovanillyl alcohol excretion (mg/24 h) 3·08* 1·49, 5·10 1·63 0·74, 2·74
Hydroxytyrosol and homovanillyl alcohol excretion (mmol/l) 1·94* 1·39, 4·06 0·84 0·50, 1·62
Study biomarkers
Oxidised DNA bases (% DNA in comet tail) 0·70* 0·56, 0·86 0·77 0·63, 1·02
Basal DNA breaks (% DNA in comet tail) 0·96 0·84, 1·08 0·62* 0·53, 0·70
Plasma total antioxidant capacity (mmol/l) 1·09 0·94, 1·24 0·64* 0·55, 0·72
*P,0·05; exact non-parametric tests; Jones & Kenward (1989).
For details of subjects and procedures, see p. 743.
Fig. 3. Oxidised DNA bases in ten volunteer subjects, as measured by the comet assay: between high-phenol extra-virgin olive oil v. low-phenol extra-virgin olive
oil treatment period, measured every 2 weeks. Values are geometric mean ratios, with 95 % CI represented by vertical bars. For details of subjects and pro-
cedures, see p. 743.
S. Salvini et al.748
in a sample of 100 volunteers randomly selected from a large
prospective study conducted in Europe – the EPIC Study
(Palli et al. 2000) – a negative association was observed
between amounts of olive oil consumption and DNA adduct
formation.
As a measure of DNA damage we used single-cell microgel
electrophoresis, or comet assay; this is a very sensitive method
initially developed as a modification of the alkaline elution
technique for the study of single- and double-strand DNA
breaks (Singh et al. 1988). It involves embedding individual
cells in agarose on a microscope slide and measuring the
degree of migration of nuclear DNA upon electrophoresis in
an alkaline buffer. The extent of migration is proportional to
the number of breaks in the DNA molecule. A modification
of the method has been described, that allows the detection
of specific lesions on DNA, such as oxidation of either purines
or pyrimidines, by the addition of endonucleases cleaving
DNA at damaged sites (Collins et al. 1993). Thus, it is poss-
ible with the comet assay to study both DNA breaks and
specific oxidative damage at the single-cell level. This pro-
cedure has been used to study basal oxidative damage in
animal models (Giovannelli et al. 2000) and in different tissues
and cells, including human lymphocytes (Pool-Zobel et al.1997;
Collins et al. 1998). In the present study, DNA bases were shown
to be protected by olive oil phenols, although the result was not
evident for DNA strand breaks.
The present study evidenced also a statistically significant
period effect, when observing DNA breaks. These were higher
at the first baseline, i.e. in the period immediately following
the summer months, an association that is probably the result
of exposure to UV radiation, as was also recently shown in
other studies from our group (Giovannelli et al. 2002, 2005).
Compliance is a critical aspect of intervention trials. Sub-
jects recruited for the present study were women in their fifties
and sixties, a population group that, in Italy, tends to consume
their meals at home and to be personally responsible for food
preparation. In fact, the study results show a very strong com-
pliance to the randomly assigned treatment; olive oil con-
sumption doubled with regard to baseline estimates,
resulting in a remarkable increase of urinary excretion of
hydroxytyrosol and its metabolite, even in subjects assigned
to the low-EVOO group. Although baseline excretion clearly
demonstrates a chronic exposure to EVOO, their quality, in
terms of phenol concentration, is currently unknown.
The availability of a marker of olive oil phenol intake is
particularly important in current research. Large epidemiologi-
cal studies, such as the EPIC study, currently conducted in ten
European countries, offer the possibility of measuring markers
of dietary intakes of food, nutrients and even contaminants.
Biological samples for almost half a million subjects across
Europe were collected at the baseline. Such samples could
even be used to characterise dietary patterns in different Med-
iterranean and European populations, not only in terms of fruit
and vegetables, using circulating carotenoids as markers of
intake (Al-Delaimy et al. 2005), but also in terms of types
and quality of ingested olive oils.
Epidemiological studies based in the Mediterranean have
shown a protection from cancer at higher levels of intake of
olive oil (Martin-Moreno et al. 1994; La Vecchia et al.
1995; Trichopoulou et al. 1995; Braga et al. 1998; Franceschi
et al. 1999). Unfortunately, due to the limited consumption of
this type of fat in non-Mediterranean countries, such results
have not been replicated and confirmed, to date, in other
parts of Europe or of the Western world. Moreover, question-
naires so far adopted in such epidemiological studies have not
allowed the exploration of the different roles of different olive
oils types (i.e. olive oil v. EVOO). Most studies were designed
when little was known about phenols in olive oils available on
the market and not much detail was included in question-
naires. This could probably explain why Greek researchers
(Trichopoulou et al. 2003) did not find a significantly protec-
tive effect of olive oil (subjects could be consuming a larger
proportion of olive oil than EVOO), despite the general
strong protection of the Mediterranean diet index evidenced
by their analyses based on the Greek component of the
EPIC study. Recently, re-interviewing approximately 2000
women from the Florence EPIC study, we observed that
EVOO are used by most Florentine women for cooking and
seasoning (G Masala and D Palli, unpublished results). This
epidemiological finding is confirmed by the present interven-
tion trial, showing a sustained excretion of hydroxytyrosol
and of its metabolite HVAlc in baseline 24 h urine samples.
Two batches of EVOO, instead of simple olive oils with
fixed amounts of phenols added, or, more extremely, ad hoc
prepared supplements with known concentration of the phe-
nols of interest, were used as treatment in the present study.
Fig. 4. Oxidised DNA bases (% DNA in comet tail) by period and treatment sequence. (a) High-phenol extra-virgin olive oil (high-EVOO) in the first period and
low-phenol EVOO (low-EVOO) in the second period; (b) low-EVOO in the first period and high-EVOO in the second period. Values are geometric means, with
95 % CI represented by vertical bars. For details of subjects and procedures, see p. 743.
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These alternative possibilities had been considered and dis-
carded. First of all, we wanted as much as possible to approxi-
mate a ‘real-life’ situation. The Tuscan population is normally
‘exposed’ to olive oil and it is used to the consumption of
high-quality EVOO. If we had supplemented a simple, non-
EVOO with known quantities of antioxidants, subjects
would have been forced to consume this low-quality olive
oil for two periods of 8 weeks (about 2 months) each and
we thought this approach was not ethical. We also decided
against the use of capsules with hydroxytyrosol and other phe-
nols, being interested in the effect of a complex mixture of
phenols from real food. Moreover, a higher bioavailability
of hydroxytyrosol as a natural component of EVOO was
demonstrated by previous work; a higher recovery of hydroxy-
tyrosol was observed when free hydroxytyrosol was adminis-
tered as EVOO, as compared with the recovery measured
when the vehicle of administration of free hydroxytyrosol
was a refined olive oil or a yoghurt (Visioli et al. 2003).
Our finding that EVOO phenols protect from oxidative
damage in healthy postmenopausal women needs to be repro-
duced in larger intervention studies on subjects of both sexes,
in different age groups, and possibly also in populations not
chronically exposed to EVOO, but offers, in vivo, new and
strong evidence of the protection exerted by high-phenol
olive oils in human subjects.
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